The osteocyte: an endocrine cell ... and more.
暂无分享,去创建一个
[1] P. Kostenuik,et al. The Receptor Activator of Nuclear Factor-κB Ligand Inhibitor Osteoprotegerin Is a Bone-Protective Agent in a Rat Model of Chronic Renal Insufficiency and Hyperparathyroidism , 2005, Calcified Tissue International.
[2] E. Bonucci,et al. Detection of osteoprotegerin (OPG) and its ligand (RANKL) mRNA and protein in femur and tibia of the rat , 2005, Journal of Molecular Histology.
[3] J. Wergedal,et al. Bone formation by osteocytes. , 1971, The American journal of physiology.
[4] R. Takagi,et al. FGF23 is mainly synthesized by osteocytes in the regularly distributed osteocytic lacunar canalicular system established after physiological bone remodeling. , 2009, Journal of electron microscopy.
[5] Hang Lee,et al. Regulation of C‐Terminal and Intact FGF‐23 by Dietary Phosphate in Men and Women , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[6] Z. Massy,et al. FGF23 is independently associated with vascular calcification but not bone mineral density in patients at various CKD stages , 2012, Osteoporosis International.
[7] R. Jilka,et al. Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: a novel mechanism for hormonal control of osteoblastogenesis. , 2005, Endocrinology.
[8] Yi Duan,et al. An Integrative Review of Mechanotransduction in Endothelial, Epithelial (Renal) and Dendritic Cells (Osteocytes) , 2011, Cellular and molecular bioengineering.
[9] A. van der Plas,et al. Sensitivity of osteocytes to biomechanical stress in vitro , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[10] Xi Jiang,et al. Dentin matrix protein 1 expression during osteoblastic differentiation, generation of an osteocyte GFP-transgene. , 2004, Bone.
[11] L. Bonewald,et al. The Amazing Osteocyte , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[12] G. Åkerström,et al. Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells. , 2007, The Journal of endocrinology.
[13] L. Bonewald,et al. Glucocorticoid dose determines osteocyte cell fate , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[14] T. Page,et al. Rat-specific decreases in platelet count caused by a humanized monoclonal antibody against sclerostin. , 2012, Toxicological sciences : an official journal of the Society of Toxicology.
[15] N. Sharkey,et al. Enhanced Osteoclastic Resorption and Responsiveness to Mechanical Load in Gap Junction Deficient Bone , 2011, PloS one.
[16] E. Burger,et al. DNA fragmentation during bone formation in neonatal rodents assessed by transferase‐mediated end labeling , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[17] L. Quarles,et al. Distinct roles for intrinsic osteocyte abnormalities and systemic factors in regulation of FGF23 and bone mineralization in Hyp mice. , 2007, American journal of physiology. Endocrinology and metabolism.
[18] Kosaku Kurata,et al. Bone Marrow Cell Differentiation Induced by Mechanically Damaged Osteocytes in 3D Gel‐Embedded Culture , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[19] K. Jepsen,et al. Osteocyte apoptosis and control of bone resorption following ovariectomy in mice. , 2010, Bone.
[20] Lynda F. Bonewald,et al. Osteocyte Wnt/β-Catenin Signaling Is Required for Normal Bone Homeostasis , 2010, Molecular and Cellular Biology.
[21] J. Laurence,et al. Degradation of MEPE, DMP1, and release of SIBLING ASARM-peptides (minhibins): ASARM-peptide(s) are directly responsible for defective mineralization in HYP. , 2008, Endocrinology.
[22] Di Chen,et al. MEPE has the properties of an osteoblastic phosphatonin and minhibin. , 2004, Bone.
[23] M. Mohammadi,et al. The parathyroid is a target organ for FGF23 in rats. , 2007, The Journal of clinical investigation.
[24] Gary S Stein,et al. The Wnt antagonist secreted frizzled-related protein-1 is a negative regulator of trabecular bone formation in adult mice. , 2004, Molecular endocrinology.
[25] J. Stock,et al. Targeted Disruption of the Osteoblast/Osteocyte Factor 45 Gene (OF45) Results in Increased Bone Formation and Bone Mass* , 2003, The Journal of Biological Chemistry.
[26] T. Hentunen,et al. Death of osteocytes turns off the inhibition of osteoclasts and triggers local bone resorption. , 2005, Biochemical and biophysical research communications.
[27] S. Cowin,et al. A model for the excitation of osteocytes by mechanical loading-induced bone fluid shear stresses. , 1994, Journal of biomechanics.
[28] A. Parfitt,et al. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. , 1998, The Journal of clinical investigation.
[29] L. Bélanger,et al. Technical approaches leading to the concept of osteocytic osteolysis. , 1967, Clinical orthopaedics and related research.
[30] S. Vilaró,et al. Identification of PA2.26 antigen as a novel cell-surface mucin-type glycoprotein that induces plasma membrane extensions and increased motility in keratinocytes. , 1999, Journal of cell science.
[31] Gregory F Weber,et al. Mechanical stress-activated integrin α5β1 induces opening of connexin 43 hemichannels , 2012, Proceedings of the National Academy of Sciences.
[32] Masaaki Inaba,et al. Increased osteocyte death and mineralization inside bone after parathyroidectomy in patients with secondary hyperparathyroidism , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[33] E. Bonucci,et al. Osteocyte ultrastructure in renal osteodystrophy , 1977, Virchows Archiv A.
[34] Masaki Hojo,et al. Calcium response in single osteocytes to locally applied mechanical stimulus: differences in cell process and cell body. , 2009, Journal of biomechanics.
[35] Mark L. Johnson,et al. Activation of β-catenin signaling in MLO-Y4 osteocytic cells versus 2T3 osteoblastic cells by fluid flow shear stress and PGE2: Implications for the study of mechanosensation in bone. , 2010, Bone.
[36] W. R. Thompson,et al. Association of the α2δ1 subunit with Cav3.2 enhances membrane expression and regulates mechanically induced ATP release in MLO‐Y4 osteocytes , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[37] T. Nagata,et al. Effect of prostaglandin E2 on mineralization of bone nodules formed by fetal rat calvarial cells , 1994, Calcified Tissue International.
[38] Extracellular calcium causes the release of calcium from intracellular stores in chick osteocytes. , 1995, Biochemical and biophysical research communications.
[39] Ivan Lobov,et al. Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor , 2002, The Journal of cell biology.
[40] J. Aubin,et al. Individual osteoblasts in the developing calvaria express different gene repertoires. , 2001, Bone.
[41] S. Reppe,et al. Zic1 transcription factor in bone: neural developmental protein regulates mechanotransduction in osteocytes , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[42] John A Latham,et al. Osteocyte control of bone formation via sclerostin, a novel BMP antagonist , 2003, The EMBO journal.
[43] Christopher R Jacobs,et al. Primary cilium‐dependent mechanosensing is mediated by adenylyl cyclase 6 and cyclic AMP in bone cells , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[44] W. Jee,et al. Sclerostin antibody increases bone mass by stimulating bone formation and inhibiting bone resorption in a hindlimb-immobilization rat model. , 2011, Bone.
[45] A. Walser,et al. Structure and functions of osteocytes in normal conditions and under the influence of parathyroid extract , 1968 .
[46] C. Jacobs,et al. A role for the primary cilium in paracrine signaling between mechanically stimulated osteocytes and mesenchymal stem cells. , 2011, Biochemical and biophysical research communications.
[47] Olivier Verborgt,et al. Spatial Distribution of Bax and Bcl‐2 in Osteocytes After Bone Fatigue: Complementary Roles in Bone Remodeling Regulation? , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[48] Jiliang Li,et al. Risedronate and alendronate suppress osteocyte apoptosis following cyclic fatigue loading. , 2007, Bone.
[49] A. Kuijpers-Jagtman,et al. Inhibition of osteocyte apoptosis by fluid flow is mediated by nitric oxide. , 2008, Biochemical and biophysical research communications.
[50] H. Yoshikawa,et al. Oxygen tension is an important mediator of the transformation of osteoblasts to osteocytes , 2007, Journal of Bone and Mineral Metabolism.
[51] G. Marotti,et al. Morphological study of intercellular junctions during osteocyte differentiation. , 1990, Bone.
[52] P. Kostenuik,et al. Targeted Deletion of the Sclerostin Gene in Mice Results in Increased Bone Formation and Bone Strength , 2008, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[53] A. Parfitt,et al. Osteoblast Programmed Cell Death (Apoptosis): Modulation by Growth Factors and Cytokines , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[54] Jean X. Jiang,et al. Gap junction and hemichannel functions in osteocytes. , 2013, Bone.
[55] L. Bonewald,et al. Establishment of an Osteocyte‐like Cell Line, MLO‐Y4 , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[56] W. Fraser,et al. Serum MEPE-ASARM-peptides are elevated in X-linked rickets (HYP): implications for phosphaturia and rickets. , 2004, The Journal of endocrinology.
[57] L. Bonewald,et al. Cell line IDG‐SW3 replicates osteoblast‐to‐late‐osteocyte differentiation in vitro and accelerates bone formation in vivo , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[58] D. Megías,et al. Podoplanin binds ERM proteins to activate RhoA and promote epithelial-mesenchymal transition , 2006, Journal of Cell Science.
[59] Y. Takeuchi,et al. Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. , 2004, The Journal of clinical investigation.
[60] J. D. Spencer,et al. The femoral head in osteonecrosis. A quantitative study of osteocyte population. , 1989, The Journal of bone and joint surgery. British volume.
[61] E. Canalis,et al. Effects of prostaglandin E2 on bone formation in cultured fetal rat calvariae: role of insulin-like growth factor-I. , 1993, Endocrinology.
[62] T. Gross,et al. Osteocyte hypoxia: a novel mechanotransduction pathway. , 1999, American journal of physiology. Cell physiology.
[63] Sheldon Weinbaum,et al. Fluid and Solute Transport in Bone: Flow-Induced Mechanotransduction. , 2009, Annual review of fluid mechanics.
[64] I. J. Singh,et al. The effects of cold‐stress, hibernation, and prolonged inactivity on bone dynamics in the golden hamster, Mesocricetus auratus , 1981, Journal of morphology.
[65] D. Rowe,et al. Use of Type I Collagen Green Fluorescent Protein Transgenes to Identify Subpopulations of Cells at Different Stages of the Osteoblast Lineage , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[66] Zhousheng Xiao,et al. Kif3a Deficiency Reverses the Skeletal Abnormalities in Pkd1 Deficient Mice by Restoring the Balance Between Osteogenesis and Adipogenesis , 2010, PloS one.
[67] P. Kostenuik,et al. Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia. , 2006, Bone.
[68] L. Lind,et al. Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community. , 2009, Atherosclerosis.
[69] O. Kennedy,et al. Activation of resorption in fatigue-loaded bone involves both apoptosis and active pro-osteoclastogenic signaling by distinct osteocyte populations. , 2012, Bone.
[70] Teruko Takano-Yamamoto,et al. Terminal Differentiation of Osteoblasts to Osteocytes Is Accompanied by Dramatic Changes in the Distribution of Actin‐Binding Proteins , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[71] K. White,et al. FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting. , 2003, The Journal of clinical investigation.
[72] C. Xian,et al. The role of osteocyte apoptosis in cancer chemotherapy‐induced bone loss , 2012, Journal of cellular physiology.
[73] J. Reeve,et al. The FASEB Journal express article 10.1096/fj.05-4221fje. Published online August 25, 2005. ©2005 FASEB , 2022 .
[74] A. Evdokiou,et al. Sclerostin is a locally acting regulator of late‐osteoblast/preosteocyte differentiation and regulates mineralization through a MEPE‐ASARM‐dependent mechanism , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[75] L. Bonewald,et al. DMP1-targeted Cre Expression in Odontoblasts and Osteocytes , 2007, Journal of dental research.
[76] T. C. Lee,et al. RANKL and OPG activity is regulated by injury size in networks of osteocyte-like cells. , 2011, Bone.
[77] S. Manolagas,et al. Glucocorticoids Induce Osteocyte Apoptosis by Blocking Focal Adhesion Kinase-mediated Survival , 2007, Journal of Biological Chemistry.
[78] Matthew J Silva,et al. Attenuated Response to In Vivo Mechanical Loading in Mice With Conditional Osteoblast Ablation of the Connexin43 Gene (Gja1) , 2008, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[79] R. Weinstein,et al. Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength. , 2004, Endocrinology.
[80] P. Nijweide,et al. Pulsating fluid flow increases nitric oxide (NO) synthesis by osteocytes but not periosteal fibroblasts--correlation with prostaglandin upregulation. , 1995, Biochemical and biophysical research communications.
[81] L. You,et al. Apoptotic osteocytes regulate osteoclast precursor recruitment and differentiation in vitro , 2011, Journal of cellular biochemistry.
[82] I. D. Padhi,et al. Serum sclerostin levels negatively correlate with parathyroid hormone levels and free estrogen index in postmenopausal women. , 2010, The Journal of clinical endocrinology and metabolism.
[83] K. Tracey,et al. HMGB1 is a bone‐active cytokine , 2008, Journal of cellular physiology.
[84] Y. Mishina,et al. The Dentin Matrix Protein 1 (Dmp1) is Specifically Expressed in Mineralized, but not Soft, Tissues during Development , 2003, Journal of dental research.
[85] C. Baud,et al. Structural changes of the periosteocytic area inVipera aspis (L.) (Ophidia, viperidae) bone tissue in various physiological conditions , 2007, Calcified Tissue International.
[86] B. Kream,et al. Regulation of bone formation (second of two parts). , 1983, The New England journal of medicine.
[87] N. Rushton,et al. Patterns of osteocytic endothelial nitric oxide synthase expression in the femoral neck cortex: differences between cases of intracapsular hip fracture and controls. , 2002, Bone.
[88] L. Bonewald,et al. Prostaglandin E2: from clinical applications to its potential role in bone- muscle crosstalk and myogenic differentiation. , 2012, Recent patents on biotechnology.
[89] B. Noble,et al. Apoptotic Bodies Convey Activity Capable of Initiating Osteoclastogenesis and Localized Bone Destruction , 2008, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[90] D. Galas,et al. Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein. , 2001, American journal of human genetics.
[91] K. Wenger,et al. Loss of myostatin (GDF8) function increases osteogenic differentiation of bone marrow-derived mesenchymal stem cells but the osteogenic effect is ablated with unloading. , 2007, Bone.
[92] N. Forest,et al. How osteoblasts become osteocytes: a decreasing matrix forming process. , 1991, Journal de biologie buccale.
[93] J. Wolff. Das Gesetz der Transformation der Knochen , 1893 .
[94] J. Heersche,et al. Effects of hind limb unloading and reloading on nitric oxide synthase expression and apoptosis of osteocytes and chondrocytes. , 2006, Bone.
[95] C. O’Brien,et al. A Novel Ligand-independent Function of the Estrogen Receptor Is Essential for Osteocyte and Osteoblast Mechanotransduction* , 2007, Journal of Biological Chemistry.
[96] F. Recklinghausen,et al. Untersuchungen über Rachitis und Osteomalacie , 1910 .
[97] M. Mcguire,et al. Expression of parathyroid hormone‐related peptide (PTHrP) and its receptor (PTH1R) during the histogenesis of cartilage and bone in the chicken mandibular process , 2002, Journal of anatomy.
[98] L. Bonewald,et al. Conditional deletion of Pkd1 in osteocytes disrupts skeletal mechanosensing in mice , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[99] Mark L. Johnson,et al. Osteocytes, mechanosensing and Wnt signaling. , 2008, Bone.
[100] R. Weinstein,et al. Connexin 43 Is Required for the Anti‐Apoptotic Effect of Bisphosphonates on Osteocytes and Osteoblasts In Vivo , 2008, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[101] A. van der Plas,et al. Characteristics and properties of osteocytes in culture , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[102] B. Pedersen,et al. LIF is a contraction-induced myokine stimulating human myocyte proliferation. , 2011, Journal of applied physiology.
[103] Daniel P Nicolella,et al. Osteocyte lacunae tissue strain in cortical bone. , 2006, Journal of biomechanics.
[104] Peng Liu,et al. Sclerostin Binds to LRP5/6 and Antagonizes Canonical Wnt Signaling* , 2005, Journal of Biological Chemistry.
[105] B. Hall,et al. Buried alive: How osteoblasts become osteocytes , 2006, Developmental dynamics : an official publication of the American Association of Anatomists.
[106] M. Robinson,et al. Sclerostin antibody treatment enhances bone strength but does not prevent growth retardation in young mice treated with dexamethasone. , 2011, Arthritis and rheumatism.
[107] H. Ris,et al. Osteocyte Shape Is Dependent on Actin Filaments and Osteocyte Processes Are Unique Actin‐Rich Projections , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[108] H. Birkedal‐Hansen,et al. The metalloproteinase MT1-MMP is required for normal development and maintenance of osteocyte processes in bone , 2005, Journal of Cell Science.
[109] D. Lacey,et al. Inhibition of sclerostin by monoclonal antibody enhances bone healing and improves bone density and strength of nonfractured bones , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[110] Shiqin Zhang,et al. Cilia-like Structures and Polycystin-1 in Osteoblasts/Osteocytes and Associated Abnormalities in Skeletogenesis and Runx2 Expression* , 2006, Journal of Biological Chemistry.
[111] D. C. Genetos,et al. Hypoxic osteocytes recruit human MSCs through an OPN/CD44-mediated pathway. , 2008, Biochemical and biophysical research communications.
[112] T. Takano-Yamamoto,et al. A three-dimensional distribution of osteocyte processes revealed by the combination of confocal laser scanning microscopy and differential interference contrast microscopy. , 2001, Bone.
[113] M. Kasper,et al. Immunohistochemical investigations on the differentiation marker protein E11 in rat calvaria, calvaria cell culture and the osteoblastic cell line ROS 17/2.8 , 1999, Histochemistry and Cell Biology.
[114] A. Pitsillides,et al. Osteocytes Use Estrogen Receptor α to Respond to Strain but Their ERα Content Is Regulated by Estrogen , 2006 .
[115] L. Bonewald,et al. The Biological Function of DMP-1 in Osteocyte Maturation Is Mediated by Its 57-kDa C-terminal Fragment , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[116] L. Bonewald,et al. Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism , 2006, Nature Genetics.
[117] S. Ejiri,et al. Matrix Mineralization as a Trigger for Osteocyte Maturation , 2008, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[118] P. Stern,et al. Bone Anabolic Responses to Mechanical Load In Vitro Involve COX-2 and Constitutive NOS , 2004, Connective tissue research.
[119] H. Melhus,et al. Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population. , 2009, Atherosclerosis.
[120] M. V. Bennett,et al. Gap junctions, electrotonic coupling, and intercellular communication. , 1978, Neurosciences Research Program bulletin.
[121] H. Higaki,et al. Evidence for the role of osteocytes in the initiation of targeted remodeling. , 2009, Technology and health care : official journal of the European Society for Engineering and Medicine.
[122] Anne Marie Kuijpers-Jagtman,et al. Osteocytes subjected to fluid flow inhibit osteoclast formation and bone resorption. , 2007, Bone.
[123] L. Bonewald,et al. Dentin Matrix Protein 1 Gene Cis-regulation , 2005, Journal of Biological Chemistry.
[124] W. Jee,et al. Treatment with a sclerostin antibody increases cancellous bone formation and bone mass regardless of marrow composition in adult female rats. , 2010, Bone.
[125] Y Wang,et al. Effects of nanomechanical bone tissue properties on bone tissue strain: implications for osteocyte mechanotransduction. , 2008, Journal of musculoskeletal & neuronal interactions.
[126] G. Passeri,et al. Cell autonomous requirement of connexin 43 for osteocyte survival: Consequences for endocortical resorption and periosteal bone formation , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[127] L. Quarles,et al. Regulation of Fibroblastic Growth Factor 23 Expression but Not Degradation by PHEX* , 2003, Journal of Biological Chemistry.
[128] B. Lanske,et al. Characterization and cloning of the E11 antigen, a marker expressed by rat osteoblasts and osteocytes. , 1996, Bone.
[129] C. Gordon,et al. Efficacy and Harms of Nasal Calcitonin in Improving Bone Density in Young Patients With Inflammatory Bowel Disease: A Randomized, Placebo-Controlled, Double-Blind Trial , 2011, The American Journal of Gastroenterology.
[130] Matthew R Allen,et al. Mechanical Stimulation of Bone in Vivo Reduces Osteocyte Expression of Sost/Sclerostin* , 2008, Journal of Biological Chemistry.
[131] Y. Yamaguchi,et al. Isolated chick osteocytes stimulate formation and bone-resorbing activity of osteoclast-like cells , 2005, Journal of Bone and Mineral Metabolism.
[132] H. Tenenhouse,et al. Dietary and serum phosphorus regulate fibroblast growth factor 23 expression and 1,25-dihydroxyvitamin D metabolism in mice. , 2005, Endocrinology.
[133] L. Bonewald,et al. Glucocorticoid-Induced Autophagy in Osteocytes , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[134] B. Komm,et al. The Wnt antagonist secreted frizzled‐related protein‐1 controls osteoblast and osteocyte apoptosis , 2005, Journal of cellular biochemistry.
[135] P. Lips,et al. Histomorphometric analysis reveals reduced bone mass and bone formation in patients with quiescent Crohn's disease. , 2011, Gastroenterology.
[136] Melissa L. Knothe Tate,et al. Whither flows the fluid in bone?" An osteocyte's perspective. , 2003 .
[137] A. Schulz,et al. Activity of osteoclastic bone resorption in primary hyperparathyroidism — a comparative electron microscopic and histomorphometric study , 1976, Calcified Tissue Research.
[138] A. Pitsillides,et al. Extracellular Matrix Mineralization Promotes E11/gp38 Glycoprotein Expression and Drives Osteocytic Differentiation , 2012, PloS one.
[139] M. Zimny,et al. Effects of Hibernation on Interradicular Alveolar Bone , 1977, Journal of dental research.
[140] S. Toyosawa,et al. Eccentric Localization of Osteocytes Expressing Enzymatic Activities, Protein, and mRNA Signals for Type 5 Tartrate-resistant Acid Phosphatase (TRAP) , 2004, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[141] L. Bonewald. Establishment and characterization of an osteocyte-like cell line, MLO-Y4 , 1999, Journal of Bone and Mineral Metabolism.
[142] Matthew R Allen,et al. Sost downregulation and local Wnt signaling are required for the osteogenic response to mechanical loading. , 2012, Bone.
[143] Y. Tsutsumi,et al. Association of CD44 with OTS-8 in tumor vascular endothelial cells. , 2000, Biochimica et biophysica acta.
[144] S. Krane,et al. Osteocyte and osteoblast apoptosis and excessive bone deposition accompany failure of collagenase cleavage of collagen. , 2000, The Journal of clinical investigation.
[145] G. Frankel,et al. Metallurgy (communication arising): Stainless-steel corrosion and MnS inclusions , 2003, Nature.
[146] M. Fukayama,et al. Podoplanin is regulated by AP-1 and promotes platelet aggregation and cell migration in osteosarcoma. , 2011, The American journal of pathology.
[147] Establishment and hormonal regulation of a conditionally transformed preosteocytic cell line from adult human bone. , 1996, Endocrinology.
[148] Hai Qing,et al. Demonstration of osteocytic perilacunar/canalicular remodeling in mice during lactation , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[149] B. Komm,et al. Transcriptional profiling of human osteoblast differentiation , 2003, Journal of cellular biochemistry.
[150] L. Bonewald,et al. Effects of Mechanical Strain on the Function of Gap Junctions in Osteocytes Are Mediated through the Prostaglandin EP2 Receptor* , 2003, Journal of Biological Chemistry.
[151] M. Quintanilla,et al. Regulation of podoplanin/PA2.26 antigen expression in tumour cells. Involvement of calpain-mediated proteolysis. , 2009, The international journal of biochemistry & cell biology.
[152] S. Harris,et al. Targeted ablation of the PTH/PTHrP receptor in osteocytes impairs bone structure and homeostatic calcemic responses. , 2011, The Journal of endocrinology.
[153] R. Duncan,et al. Fluid Shear‐Induced ATP Secretion Mediates Prostaglandin Release in MC3T3‐E1 Osteoblasts , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[154] L. Quarles,et al. Phosphorylated acidic serine-aspartate-rich MEPE-associated motif peptide from matrix extracellular phosphoglycoprotein inhibits phosphate regulating gene with homologies to endopeptidases on the X-chromosome enzyme activity. , 2007, The Journal of endocrinology.
[155] A. Go,et al. FGF23 induces left ventricular hypertrophy. , 2011, The Journal of clinical investigation.
[156] E. Bonucci,et al. Effects of intermittent parathyroid hormone (PTH) administration on SOST mRNA and protein in rat bone , 2007, Journal of Molecular Histology.
[157] L. Raisz,et al. Prostaglandins in bone: bad cop, good cop? , 2010, Trends in Endocrinology & Metabolism.
[158] A. Poustka,et al. A gene (PEX) with homologies to endopeptidases is mutated in patients with X–linked hypophosphatemic rickets , 1995, Nature Genetics.
[159] Sheldon Weinbaum,et al. Mechanotransduction and strain amplification in osteocyte cell processes. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[160] O. Verborgt,et al. Loss of Osteocyte Integrity in Association with Microdamage and Bone Remodeling After Fatigue In Vivo , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[161] M. HELLER-STEINBERG,et al. Ground substance, bone salts, and cellular activity in bone formation and destruction. , 1951, The American journal of anatomy.
[162] R. Bacabac,et al. Tumor necrosis factor alpha and interleukin-1beta modulate calcium and nitric oxide signaling in mechanically stimulated osteocytes. , 2009, Arthritis and rheumatism.
[163] L. Ferrucci,et al. Relationship of serum fibroblast growth factor 23 with cardiovascular disease in older community-dwelling women. , 2011, European journal of endocrinology.
[164] A. Boskey,et al. MEPE’s Diverse Effects on Mineralization , 2009, Calcified Tissue International.
[165] M Dioszegi,et al. Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST). , 2001, Human molecular genetics.
[166] S. Manolagas,et al. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. , 2000, Endocrine reviews.
[167] H. Dvorak,et al. T1α/podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema , 2003, The EMBO journal.
[168] J. Shaughnessy,et al. Inhibiting Dickkopf‐1 (Dkk1) Removes Suppression of Bone Formation and Prevents the Development of Osteolytic Bone Disease in Multiple Myeloma , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[169] J. Reeve,et al. NOS Isoforms in Adult Human Osteocytes: Multiple Pathways of NO Regulation? , 2004, Calcified Tissue International.
[170] A. Hedge,et al. Matrix extracellular phosphoglycoprotein (MEPE) is a new bone renal hormone and vascularization modulator. , 2009, Endocrinology.
[171] G. Marotti,et al. Quantitative evaluation on osteocyte canalicular density in human secondary osteons. , 1995, Bone.
[172] Y. Mikuni‐Takagaki,et al. Distinct responses of different populations of bone cells to mechanical stress. , 1996, Endocrinology.
[173] Stephen B Doty,et al. Delineating bone's interstitial fluid pathway in vivo. , 2004, Bone.
[174] D. Woodbury,et al. The effects of prostaglandin E2 in growing rats: Increased metaphyseal hard tissue and cortico-endosteal bone formation , 2007, Calcified Tissue International.
[175] T. Hentunen,et al. Conditioned medium from osteocytes stimulates the proliferation of bone marrow mesenchymal stem cells and their differentiation into osteoblasts. , 2004, Experimental cell research.
[176] L. Bonewald,et al. Unique Roles of Phosphorus in Endochondral Bone Formation and Osteocyte Maturation , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[177] M. Giacca,et al. A novel animal model to study non-spontaneous bisphosphonates osteonecrosis of jaw. , 2010, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[178] M. McKee,et al. MEPE‐ASARM Peptides Control Extracellular Matrix Mineralization by Binding to Hydroxyapatite: An Inhibition Regulated by PHEX Cleavage of ASARM , 2008, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[179] D. Rowe,et al. Identification of differentially expressed genes between osteoblasts and osteocytes. , 2009, Bone.
[180] Jian Q. Feng,et al. Dentin Matrix Protein 1, a Target Molecule for Cbfa1 in Bone, Is a Unique Bone Marker Gene , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[181] R. Unwin,et al. Matrix extracellular phosphoglycoprotein causes phosphaturia in rats by inhibiting tubular phosphate reabsorption. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[182] L. Bonewald,et al. Identification of osteocyte‐selective proteins , 2010, Proteomics.
[183] M. J. Pead,et al. Indomethacin modulation of load-related stimulation of new bone formationin vivo , 2007, Calcified Tissue International.
[184] J. Zwerina,et al. Neutralisation of Dkk-1 protects from systemic bone loss during inflammation and reduces sclerostin expression , 2010, Annals of the rheumatic diseases.
[185] T. Komori,et al. Dentin Matrix Protein 1 Is Predominantly Expressed in Chicken and Rat Osteocytes But Not in Osteoblasts , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[186] D. Zaffe,et al. Osteocyte differentiation in the tibia of newborn rabbit: an ultrastructural study of the formation of cytoplasmic processes. , 1990, Acta anatomica.
[187] Miikka Vikkula,et al. LDL Receptor-Related Protein 5 (LRP5) Affects Bone Accrual and Eye Development , 2001, Cell.
[188] L. Bonewald,et al. Mechanosensation and Transduction in Osteocytes. , 2006, BoneKEy osteovision.
[189] G. Marotti. The structure of bone tissues and the cellular control of their deposition. , 1996, Italian journal of anatomy and embryology = Archivio italiano di anatomia ed embriologia.
[190] Christopher Price,et al. Real-Time Measurement of Solute Transport Within the Lacunar-Canalicular System of Mechanically Loaded Bone: Direct Evidence for Load-Induced Fluid Flow , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[191] L. Lind,et al. Relationship between circulating FGF23 and total body atherosclerosis in the community. , 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[192] T. Meitinger,et al. Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23 , 2000, Nature Genetics.
[193] P. Nijweide,et al. Biochemical and histological studies on various bone cell preparations , 2006, Calcified Tissue International.
[194] L. Bonewald,et al. MLO‐Y4 Osteocyte‐Like Cells Support Osteoclast Formation and Activation , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[195] L. Churchill,et al. Matrix extracellular phosphoglycoprotein inhibits phosphate transport. , 2008, Journal of the American Society of Nephrology : JASN.
[196] J M Polak,et al. Mechanical Strain Stimulates Nitric Oxide Production by Rapid Activation of Endothelial Nitric Oxide Synthase in Osteocytes , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[197] S. Doty. Morphological evidence of gap junctions between bone cells , 2006, Calcified Tissue International.
[198] Mai-Szu Wu,et al. Fibroblast Growth Factor 23: A Possible Cause of Left Ventricular Hypertrophy in Hemodialysis Patients , 2009, The American journal of the medical sciences.
[199] Minqi Li,et al. Targeted ablation of osteocytes induces osteoporosis with defective mechanotransduction. , 2007, Cell metabolism.
[200] T. Meitinger,et al. Distribution of mutations in the PEX gene in families with X-linked hypophosphataemic rickets (HYP). , 1997, Human molecular genetics.
[201] S. Schulz,et al. Immunohistochemical identification of the PTHR1 parathyroid hormone receptor in normal and neoplastic human tissues. , 2010, European journal of endocrinology.
[202] Jenneke Klein-Nulend,et al. Inhibition of Osteoclastogenesis by Mechanically Loaded Osteocytes: Involvement of MEPE , 2010, Calcified Tissue International.
[203] M. Kneissel,et al. SOST is a target gene for PTH in bone. , 2005, Bone.
[204] L. Bonewald,et al. Tissue strain amplification at the osteocyte lacuna: a microstructural finite element analysis. , 2007, Journal of biomechanics.
[205] D. Rowe,et al. Directing the expression of a green fluorescent protein transgene in differentiated osteoblasts: comparison between rat type I collagen and rat osteocalcin promoters. , 2002, Bone.
[206] M. Mohammadi,et al. FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1. , 2009, American journal of physiology. Renal physiology.
[207] E H Burger,et al. The production of nitric oxide and prostaglandin E(2) by primary bone cells is shear stress dependent. , 2001, Journal of biomechanics.
[208] J. Silver,et al. PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop. , 2010, American journal of physiology. Renal physiology.
[209] P. Nijweide,et al. Osteocyte‐Specific Monoclonal Antibody MAb OB7.3 Is Directed Against Phex Protein , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[210] M. Edmonds,et al. Thiazolidinediones induce osteocyte apoptosis and increase sclerostin expression , 2010, Diabetic medicine : a journal of the British Diabetic Association.
[211] J. Aubin,et al. The mature osteoblast phenotype is characterized by extensive plasticity. , 1997, Experimental cell research.
[212] L. Bonewald,et al. Establishment of an Osteoid Preosteocyte‐like Cell MLO‐A5 That Spontaneously Mineralizes in Culture , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[213] J. Polak,et al. Apoptosis--a significant cause of bone cell death in osteonecrosis of the femoral head. , 2004, The Journal of bone and joint surgery. British volume.
[214] Toshitaka Nakamura,et al. Role of Inducible Nitric Oxide Synthase in Skeletal Adaptation to Acute Increases in Mechanical Loading , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[215] Ron Y Kwon,et al. Primary cilia mediate mechanosensing in bone cells by a calcium-independent mechanism , 2007, Proceedings of the National Academy of Sciences.
[216] T. Shimada,et al. Therapeutic Effects of Anti‐FGF23 Antibodies in Hypophosphatemic Rickets/Osteomalacia , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[217] L. Bonewald,et al. Gene expression signatures of a fibroblastoid preosteoblast and cuboidal osteoblast cell model compared to the MLO-Y4 osteocyte cell model. , 2009, Bone.
[218] P. Roberson,et al. Intermittent parathyroid hormone administration counteracts the adverse effects of glucocorticoids on osteoblast and osteocyte viability, bone formation, and strength in mice. , 2010, Endocrinology.
[219] P. Roberson,et al. Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin. , 1999, The Journal of clinical investigation.
[220] A. E. Espinoza Orías,et al. Overexpression of DMP1 accelerates mineralization and alters cortical bone biomechanical properties in vivo. , 2012, Journal of the mechanical behavior of biomedical materials.
[221] S. Krieger,et al. Sp1/Sp3 and DNA-methylation contribute to basal transcriptional activation of human podoplanin in MG63 versus Saos-2 osteoblastic cells , 2007, BMC Molecular Biology.
[222] M. Takagi,et al. In situ Localization and in vitro Expression of Osteoblast/Osteocyte Factor 45 mRNA during Bone Cell Differentiation , 2002, The Histochemical Journal.
[223] D. Fyhrie,et al. Modulation of sclerostin expression by mechanical loading and bone morphogenetic proteins in osteogenic cells. , 2009, Biorheology.
[224] T. Meitinger,et al. Pex gene deletions in Gy and Hyp mice provide mouse models for X-linked hypophosphatemia. , 1997, Human molecular genetics.
[225] Bente Klarlund Pedersen,et al. Muscles and their myokines , 2011, Journal of Experimental Biology.
[226] Lynda F. Bonewald,et al. Prostaglandin Promotion of Osteocyte Gap Junction Function through Transcriptional Regulation of Connexin 43 by Glycogen Synthase Kinase 3/β-Catenin Signaling , 2009, Molecular and Cellular Biology.
[227] M. Inaba,et al. FGF-23 in patients with end-stage renal disease on hemodialysis. , 2004, Kidney international.
[228] L. Quarles,et al. Inhibition of MEPE cleavage by Phex. , 2002, Biochemical and biophysical research communications.
[229] R. Weinstein,et al. Apoptosis of osteocytes in glucocorticoid-induced osteonecrosis of the hip. , 2000, The Journal of clinical endocrinology and metabolism.
[230] M. Bouxsein,et al. Control of Bone Mass and Remodeling by PTH Receptor Signaling in Osteocytes , 2008, PloS one.
[231] M. Farach-Carson,et al. Expression of voltage sensitive calcium channel (VSCC) L‐type Cav1.2 (α1C) and T‐type Cav3.2 (α1H) subunits during mouse bone development , 2005 .
[232] G. Marotti,et al. Osteocyte dendrogenesis in static and dynamic bone formation: an ultrastructural study. , 2004, The anatomical record. Part A, Discoveries in molecular, cellular, and evolutionary biology.
[233] C. Ohlsson,et al. Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis. , 2004, Endocrinology.
[234] P. Mcneil,et al. Role of muscle-derived growth factors in bone formation. , 2010, Journal of musculoskeletal & neuronal interactions.
[235] L. Bélanger,et al. PARATHORMONE-INDUCED OSTEOLYSIS IN DOGS. A MICRORADIOGRAPHIC AND ALPHARADIOGRAPHIC SURVEY. , 1964, The Journal of bone and joint surgery. American volume.
[236] J. Aubin,et al. Determination of numbers of osteoprogenitors present in isolated fetal rat calvaria cells in vitro. , 1989, Developmental biology.
[237] B. Barlogie,et al. Characterization of Wnt/β‐catenin signalling in osteoclasts in multiple myeloma , 2010, British journal of haematology.
[238] P. Kostenuik,et al. Inhibition of sclerostin by monoclonal antibody increases bone formation, bone mass, and bone strength in aged male rats , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[239] E. Russo,et al. Jaw Osteonecrosis in Patients Treated with Bisphosphonates: An Ultrastructural Study , 2010, Ultrastructural pathology.
[240] S. Kaptoge,et al. Osteocytic Expression of Constitutive NO Synthase Isoforms in the Femoral Neck Cortex: A Case‐Control Study of Intracapsular Hip Fracture , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[241] K. Metsikkö,et al. Isolated primary osteocytes express functional gap junctions in vitro , 2006, Cell and Tissue Research.
[242] Jiliang Li,et al. The P2X7 Nucleotide Receptor Mediates Skeletal Mechanotransduction* , 2005, Journal of Biological Chemistry.
[243] Daniel J Lightwood,et al. Two doses of sclerostin antibody in cynomolgus monkeys increases bone formation, bone mineral density, and bone strength , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[244] P. Kostenuik,et al. Effects of parathyroid hormone treatment on circulating sclerostin levels in postmenopausal women. , 2010, The Journal of clinical endocrinology and metabolism.
[245] S. E. Harris,et al. MEPE expression in osteocytes during orthodontic tooth movement. , 2007, Archives of oral biology.
[246] S. Ashrafi,et al. The Canalicular Structure of Compact Bone in the Rat at Different Ages , 2002, Microscopy and Microanalysis.
[247] Xi Jiang,et al. Neuropeptide Y is expressed by osteocytes and can inhibit osteoblastic activity , 2009, Journal of cellular biochemistry.
[248] Daniel P Nicolella,et al. Dendritic processes of osteocytes are mechanotransducers that induce the opening of hemichannels , 2010, Proceedings of the National Academy of Sciences.
[249] A. van der Plas,et al. Isolation and purification of osteocytes , 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[250] E. Kastritis,et al. Elevated circulating sclerostin correlates with advanced disease features and abnormal bone remodeling in symptomatic myeloma: Reduction post‐bortezomib monotherapy , 2012, International journal of cancer.
[251] R. Suzuki,et al. Some osteocytes released from their lacunae are embedded again in the bone and not engulfed by osteoclasts during bone remodeling , 2000, Anatomy and Embryology.
[252] A. Robling,et al. The Wnt Co-receptor LRP5 Is Essential for Skeletal Mechanotransduction but Not for the Anabolic Bone Response to Parathyroid Hormone Treatment* , 2006, Journal of Biological Chemistry.
[253] S. Fernandez,et al. Zoledronic acid decreases bone formation without causing osteocyte death in mice. , 2009, Archives of oral biology.
[254] A. Parfitt,et al. Mechanical stimulation prevents osteocyte apoptosis: requirement of integrins, Src kinases, and ERKs. , 2005, American journal of physiology. Cell physiology.
[255] A. E. El Haj,et al. Hormonally-regulated expression of voltage-operated Ca(2+) channels in osteocytic (MLO-Y4) cells. , 2001, Biochemical and biophysical research communications.
[256] E. Puscheck,et al. Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[257] Jenneke Klein-Nulend,et al. Osteocytes subjected to pulsating fluid flow regulate osteoblast proliferation and differentiation. , 2006, Biochemical and biophysical research communications.
[258] L. Bonewald,et al. Mechanical strain opens connexin 43 hemichannels in osteocytes: a novel mechanism for the release of prostaglandin. , 2005, Molecular biology of the cell.
[259] S. Cowin,et al. Ultrastructure of the osteocyte process and its pericellular matrix. , 2004, The anatomical record. Part A, Discoveries in molecular, cellular, and evolutionary biology.
[260] E. B. Ruth. Basophilic islands in osseous tissue and their relation to resorption , 1961, The Anatomical record.
[261] D. Carnes,et al. Surface plasmon resonance (SPR) confirms that MEPE binds to PHEX via the MEPE-ASARM motif: a model for impaired mineralization in X-linked rickets (HYP). , 2005, Bone.
[262] Stephen E. Harris,et al. E11/gp38 Selective Expression in Osteocytes: Regulation by Mechanical Strain and Role in Dendrite Elongation , 2006, Molecular and Cellular Biology.
[263] C. Jacobs,et al. Functional Gap Junctions Between Osteocytic and Osteoblastic Cells , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[264] E. Farrow,et al. Parathyroid hormone receptor signaling in osteocytes increases the expression of fibroblast growth factor-23 in vitro and in vivo. , 2011, Bone.
[265] D B Kimmel,et al. Prostaglandin E2 increases the skeletal response to mechanical loading. , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[266] J. Aubin,et al. Advances in the osteoblast lineage. , 1998, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[267] A. Teti,et al. Mature osteocytes behaviour in a repletion period: the occurrence of osteoplastic activity. , 1983, Basic and applied histochemistry.
[268] M. Collins,et al. Serum levels of matrix extracellular phosphoglycoprotein (MEPE) in normal humans correlate with serum phosphorus, parathyroid hormone and bone mineral density. , 2004, The Journal of clinical endocrinology and metabolism.
[269] L. Bonewald,et al. Mechanical Loading Stimulates Dentin Matrix Protein 1 (DMP1) Expression in Osteocytes In Vivo , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[270] B. Katzenellenbogen,et al. Nongenotropic, Sex-Nonspecific Signaling through the Estrogen or Androgen Receptors Dissociation from Transcriptional Activity , 2001, Cell.
[271] E. Nunez,et al. Activation of osteoclasts and the repopulation of bone surfaces following hibernation in the bat, Myotis lucifugus , 1985, The Anatomical record.
[272] G. Loots,et al. Parathyroid Hormone (PTH)–Induced Bone Gain Is Blunted in SOST Overexpressing and Deficient Mice , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[273] J. Reeve,et al. The death of osteocytes via apoptosis accompanies estrogen withdrawal in human bone. , 1997, The Journal of clinical endocrinology and metabolism.
[274] T. Bellido. Antagonistic interplay between mechanical forces and glucocorticoids in bone: A tale of kinases , 2010, Journal of cellular biochemistry.
[275] C. Palumbo. A three-dimensional ultrastructural study of osteoid-osteocytes in the tibia of chick embryos , 2004, Cell and Tissue Research.
[276] K. Hirokawa,et al. Expression Profiles of Receptor Activator of Nuclear Factor κB Ligand, Receptor Activator of Nuclear Factor κB, and Osteoprotegerin Messenger RNA in Aged and Ovariectomized Rat Bones , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[277] S. Ott. Sclerostin and Wnt signaling--the pathway to bone strength. , 2005, The Journal of clinical endocrinology and metabolism.
[278] C. Benhamou,et al. Low bone accrual is associated with osteocyte apoptosis in alcohol-induced osteopenia. , 2011, Bone.
[279] P. Niederer,et al. In vivo tracer transport through the lacunocanalicular system of rat bone in an environment devoid of mechanical loading. , 1998, Bone.
[280] A. Hedge,et al. ASARM peptides: PHEX-dependent and -independent regulation of serum phosphate. , 2011, American journal of physiology. Renal physiology.
[281] M. Balooch,et al. Glucocorticoid‐Treated Mice Have Localized Changes in Trabecular Bone Material Properties and Osteocyte Lacunar Size That Are Not Observed in Placebo‐Treated or Estrogen‐Deficient Mice , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[282] Stephen C Cowin,et al. Estimation of bone permeability using accurate microstructural measurements. , 2006, Journal of biomechanics.
[283] R. Suzuki,et al. The reaction of osteoclasts when releasing osteocytes from osteocytic lacunae in the bone during bone modeling. , 2003, Tissue & cell.
[284] N. Itoh,et al. Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain. , 2000, Biochemical and biophysical research communications.
[285] L. Bonewald,et al. Studying osteocyte function using the cell lines MLO-Y4 and MLO-A5. , 2012, Methods in molecular biology.
[286] J. Robb,et al. Electrophysiological Responses of Human Bone Cells to Mechanical Stimulation: Evidence for Specific Integrin Function in Mechanotransduction , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[287] E. Katchburian,et al. Electron microscopy of developing calvaria reveals images that suggest that osteoclasts engulf and destroy osteocytes during bone resorption , 1990, Calcified Tissue International.
[288] M. Hamrick. A Role for Myokines in Muscle-Bone Interactions , 2011, Exercise and sport sciences reviews.
[289] D. Rao,et al. Reduced Iliac Cancellous Osteocyte Density in Patients With Osteoporotic Vertebral Fracture , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[290] P. Roberson,et al. Osteoprotegerin prevents glucocorticoid-induced osteocyte apoptosis in mice. , 2011, Endocrinology.
[291] C A Baud,et al. Submicroscopic structure and functional aspects of the osteocyte. , 1968, Clinical orthopaedics and related research.
[292] K. Michaëlsson,et al. Circulating Fibroblast Growth Factor-23 Is Associated With Fat Mass and Dyslipidemia in Two Independent Cohorts of Elderly Individuals , 2011, Arteriosclerosis, thrombosis, and vascular biology.
[293] M. Forwood,et al. Inducible cyclo‐oxygenase (COX‐2) mediates the induction of bone formation by mechanical loading in vivo , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[294] L. Bonewald,et al. Mechanism by which MLO-A5 Late Osteoblasts/Early Osteocytes Mineralize in Culture: Similarities with Mineralization of Lamellar Bone , 2006, Calcified Tissue International.
[295] S. Kato,et al. Inhibition of Intestinal Sodium‐dependent Inorganic Phosphate Transport by Fibroblast Growth Factor 23 , 2005, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.
[296] L. Bonewald,et al. Isolation and culture of primary osteocytes from the long bones of skeletally mature and aged mice. , 2012, BioTechniques.
[297] A. Neri,et al. Increased osteocyte death in multiple myeloma patients: role in myeloma-induced osteoclast formation , 2012, Leukemia.
[298] X. Guo,et al. Osteocytic network is more responsive in calcium signaling than osteoblastic network under fluid flow , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[299] H. Rauvala,et al. Osteocyte-derived HB-GAM (pleiotrophin) is associated with bone formation and mechanical loading. , 2009, Bone.
[300] Jie J. Zheng,et al. The LRP5 High-Bone-Mass G171V Mutation Disrupts LRP5 Interaction with Mesd , 2004, Molecular and Cellular Biology.
[301] E. Posvar,et al. Single‐dose, placebo‐controlled, randomized study of AMG 785, a sclerostin monoclonal antibody , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[302] J. Wergedal,et al. DISTRIBUTION OF ACID AND ALKALINE PHOSPHATASE ACTIVITY IN UNDEMINERALIZED SECTIONS OF THE RAT TIBIAL DIAPHYSIS , 1969, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[303] H. Jüppner,et al. Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers. , 2003, Kidney international.
[304] Jian Q. Feng,et al. Bone proteins PHEX and DMP1 regulate fibroblastic growth factor Fgf23 expression in osteocytes through a common pathway involving FGF receptor (FGFR) signaling , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[305] K. Okawa,et al. Klotho converts canonical FGF receptor into a specific receptor for FGF23 , 2006, Nature.
[306] C. Halleux,et al. Mef2c deletion in osteocytes results in increased bone mass , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[307] D. Salter,et al. CD44 expression in human bone: A novel marker of osteocytic differentiation , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[308] A. Griffiths,et al. Natural history of bone metabolism and bone mineral density in children with inflammatory bowel disease , 2007, Inflammatory bowel diseases.
[309] A. E. El Haj,et al. Three types of K(+) currents in murine osteocyte-like cells (MLO-Y4). , 2001, Bone.
[310] Kosaku Kurata,et al. Evidence for osteocyte regulation of bone homeostasis through RANKL expression , 2011, Nature Medicine.
[311] L. Bonewald. Osteocytes as Dynamic Multifunctional Cells , 2007, Annals of the New York Academy of Sciences.
[312] Lynda F. Bonewald,et al. CHAPTER 8 – Osteocytes , 2008 .
[313] L. Bonewald,et al. Dynamics of the transition from osteoblast to osteocyte , 2010, Annals of the New York Academy of Sciences.
[314] Mark L. Johnson,et al. Skeletal muscle secreted factors prevent glucocorticoid-induced osteocyte apoptosis through activation of β-catenin. , 2012, European cells & materials.
[315] Xi Jiang,et al. Pathogenic role of Fgf23 in Hyp mice. , 2006, American journal of physiology. Endocrinology and metabolism.
[316] Hai Qing,et al. Mechanical Induction of PGE2 in Osteocytes Blocks Glucocorticoid-Induced Apoptosis Through Both the β-Catenin and PKA Pathways , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[317] Jinhu Xiong,et al. Matrix-embedded cells control osteoclast formation , 2011, Nature Medicine.
[318] T. Martin,et al. Localization of RANKL (receptor activator of NF kappa B ligand) mRNA and protein in skeletal and extraskeletal tissues. , 1999, Bone.
[319] Guoyin Feng,et al. Sclerostin Mediates Bone Response to Mechanical Unloading Through Antagonizing Wnt/β‐Catenin Signaling , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.